11. S-28-01 Characterising applicability domains of generic in vitro distribution kinetic and physiologically based kinetic models. (1st September 2022) Authors: Kramer, N.; Paini, A.; Proenca, S.; Geci, R.; Yang, H.; Schaller, S. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. SOC-V-09 Development of quantitative adverse outcome pathways to address the effects of PFAS on cholesterol metabolism. Benchmarking with human epidemiological data and comparison with threshold values. (1st September 2022) Authors: Westerhout, J.; Krishnan, S.; Schillemans, T.; Åkesson, A.; Kramer, N.; Louisse, J.; Legler, J.; Princen, H.; Stierum, R. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗